Home Your basket
• Atelectasis of the maxill...
   Price 8.50 €
• Pharyngolaryngectomy for ...
   Price 10.50 €
• A case of laryngeal sialo...
   Price 10.50 €
• The EXIT procedure: Princ...
   Price 8.50 €
• Assessing efficacy of voi...
   Price 5.50 €
• Retrosigmoid vestibular n...
   Price 5.50 €
• The pedicle superficial t...
   Price 10.50 €
• Periphery, central and ps...
   Price 10.50 €
• Face and neck lift using ...
   Price 14.00 €
• Traditional and emerging ...
   Price 10.50 €
• The value of fine-needle ...
   Price 10.50 €
• Stuttering of the “Miror”...
   Price 5.50 €
• Cutaneous horn of the pin...
   Price 5.50 €
• Migrant foreign body of t...
   Price 10.50 €
• Treatment by enlargement ...
   Price 10.50 €
• Middle ear tuberculosis e...
   Price 5.50 €
• Choanal atresia: therapeu...
   Price 10.50 €
• Cholesteatoma by osteoma ...
   Price 8.50 €
• Results of six years expe...
   Price 8.50 €
• Management of cervical ly...
   Price 10.50 €
• When to suspect a perilym...
   Price 10.50 €
• From the physiologic perf...
   Price 14.00 €
• Cowden syndrome: Otolaryn...
   Price 12.00 €
• Choanal atresia : a retro...
   Price 8.50 €
• Pulsatile tinnitus and ve...
   Price 8.50 €
• Arteriovenous haemangioma...
   Price 8.50 €
• Overlay versus underlay t...
   Price 10.50 €
• Electrorhinomanometric ev...
   Price 10.50 €
• The ultra-rapid cinematog...
   Price 10.50 €
• Evolution of voice assess...
   Price 10.50 €
• New technique of myringop...
   Price 5.50 €
• Osteoblastoma of the eth...
   Price 10.50 €
• Evaluation of the presenc...
   Price 12.50 €
• A survey of current wound...
   Price 5.50 €

Total Order 318.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Download
o Issue N# 1 - 2000 o

OTONEUROLOGY

The natural history of untreated vestibular schwannomas. Is there a role for conservative management ?


Authors : R. M. Walsh, A. P. Bath, M. L. Bance, A. Keller, C. H. Tator, J. A. Rutka (Toronto)

Ref. : Rev Laryngol Otol Rhinol. 2000;121,1:21-26.

Article published in english



Summary : Objective: the aim of this study was to investigate the natural history and outcome following the conservative management of a group of patients with unilateral vestibular schwannomas. Methods: 72 patients with a radiological diagnosis of unilateral vestibular schwannoma were managed conservatively because of poor general health, advanced age, patient preference, small tumour size, minimal symptoms, or tumour in the only / better hearing ear. All patients underwent serial magnetic resonance imaging for assessment of tumour growth, according to American Academy of Otolaryngology-Head & Neck Surgery guidelines (1995). The mean duration of follow-up was 37.8 months (range 12-194 months). Patients were deemed to have failed conservative management if there was evidence of continuous or rapid radiological tumour growth, and / or increasing symptoms or signs. Results : the mean tumour growth rate was 1.16 mm/year (range -0.75 to 9.65 mm/year). Approximately 83% of tumours grew at less than 2 mm/year. Significant tumour growth (total growth > 1 mm) was seen in 36.4%, no or insignificant growth (0 - 1 mm) in 50%, and negative growth (< 0 mm) in 13.6% of tumours. The growth rate of cerebellopontine angle (CPA) tumours (1.4 mm/year) was significantly greater than that of tumours limited to the internal auditory canal (IAC) (0.2 mm/year) (p = 0.001). Failure of conservative management, in which active treatment was required, occurred in 15.3%. The outcome of these patients appeared to be as favourable as those who underwent primary treatment, without a period of conservative management. The growth rate of tumours in patients who failed conservative management (4.2 mm/year) was significantly greater than that in patients who did not fail (0.5 mm/year) (p < 0.01). No factors predictive of tumour growth were identified. Deterioration of mean pure tone average (0.5, 1, 2, 3 kHz) and speech discrimination scores occurred regardless of whether radiological tumour growth was demonstrated or not. Conclusions: The majority of vestibular schwannomas are slow growing, although, CPA tumours appear to grow faster than IAC tumours. Deterioration of auditory function occurs even in the absence of tumour growth. Although most Otolaryngologists and Neurosurgeons would agree that the treatment of choice for the majority of vestibular schwannomas is microsurgery, there remains a small group of patients in whom a conservative management approach may be a desirable alternative.


|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE